The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases

P. L. De Jager, D. Franchimont, A. Waliszewska, A. Bitton, A. Cohen, D. Langelier, J. Belaiche, S. Vermeire, L. Farwell, A. Goris, C. Libioulle, N. Jani, T. Dassopoulos, G. P. Bromfield, B. Dubois, J. H. Cho, S. R. Brant, R. H. Duerr, H. Yang, J. I. RotterM. S. Silverberg, A. H. Steinhart, M. J. Daly, D. K. Podolsky, E. Louis, D. A. Hafler, J. D. Rioux

Research output: Contribution to journalArticle

Abstract

The intestinal flora has long been thought to play a role either in initiating or in exacerbating the inflammatory bowel diseases (IBD). Host defenses, such as those mediated by the Toll-like receptors (TLR), are critical to the host/pathogen interaction and have been implicated in IBD pathophysiology. To explore the association of genetic variation in TLR pathways with susceptibility to IBD, we performed a replication study and pooled analyses of the putative IBD risk alleles in NFKB1 and TLR4, and we performed a haplotype-based screen for association to IBD in the TLR genes and a selection of their adaptor and signaling molecules. Our genotyping of 1539 cases of IBD and pooled analysis of 4805 cases of IBD validates the published association of a TLR4 allele with risk of IBD (odds ratio (OR): 1.30, 95% confidence interval (CI): 1.15-1.48; P=0.00017) and Crohn's disease (OR: 1.33, 95% CI: 1.16-1.54; P=0.000035) but not ulcerative colitis. We also describe novel suggestive evidence that TIRAP (OR: 1.16, 95% CI: 1.04-1.30; P=0.007) has a modest effect on risk of IBD. Our analysis, therefore, offers additional evidence that the TLR4 pathway - in this case, TLR4 and its signaling molecule TIRAP - plays a role in susceptibility to IBD.

Original languageEnglish (US)
Pages (from-to)387-397
Number of pages11
JournalGenes and Immunity
Volume8
Issue number5
DOIs
StatePublished - Jul 2007

Fingerprint

Inflammatory Bowel Diseases
Toll-Like Receptors
Odds Ratio
Confidence Intervals
Alleles
Host-Pathogen Interactions
Ulcerative Colitis
Crohn Disease
Haplotypes

ASJC Scopus subject areas

  • Genetics(clinical)
  • Immunology
  • Genetics

Cite this

De Jager, P. L., Franchimont, D., Waliszewska, A., Bitton, A., Cohen, A., Langelier, D., ... Rioux, J. D. (2007). The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes and Immunity, 8(5), 387-397. https://doi.org/10.1038/sj.gene.6364398

The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. / De Jager, P. L.; Franchimont, D.; Waliszewska, A.; Bitton, A.; Cohen, A.; Langelier, D.; Belaiche, J.; Vermeire, S.; Farwell, L.; Goris, A.; Libioulle, C.; Jani, N.; Dassopoulos, T.; Bromfield, G. P.; Dubois, B.; Cho, J. H.; Brant, S. R.; Duerr, R. H.; Yang, H.; Rotter, J. I.; Silverberg, M. S.; Steinhart, A. H.; Daly, M. J.; Podolsky, D. K.; Louis, E.; Hafler, D. A.; Rioux, J. D.

In: Genes and Immunity, Vol. 8, No. 5, 07.2007, p. 387-397.

Research output: Contribution to journalArticle

De Jager, PL, Franchimont, D, Waliszewska, A, Bitton, A, Cohen, A, Langelier, D, Belaiche, J, Vermeire, S, Farwell, L, Goris, A, Libioulle, C, Jani, N, Dassopoulos, T, Bromfield, GP, Dubois, B, Cho, JH, Brant, SR, Duerr, RH, Yang, H, Rotter, JI, Silverberg, MS, Steinhart, AH, Daly, MJ, Podolsky, DK, Louis, E, Hafler, DA & Rioux, JD 2007, 'The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases', Genes and Immunity, vol. 8, no. 5, pp. 387-397. https://doi.org/10.1038/sj.gene.6364398
De Jager PL, Franchimont D, Waliszewska A, Bitton A, Cohen A, Langelier D et al. The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes and Immunity. 2007 Jul;8(5):387-397. https://doi.org/10.1038/sj.gene.6364398
De Jager, P. L. ; Franchimont, D. ; Waliszewska, A. ; Bitton, A. ; Cohen, A. ; Langelier, D. ; Belaiche, J. ; Vermeire, S. ; Farwell, L. ; Goris, A. ; Libioulle, C. ; Jani, N. ; Dassopoulos, T. ; Bromfield, G. P. ; Dubois, B. ; Cho, J. H. ; Brant, S. R. ; Duerr, R. H. ; Yang, H. ; Rotter, J. I. ; Silverberg, M. S. ; Steinhart, A. H. ; Daly, M. J. ; Podolsky, D. K. ; Louis, E. ; Hafler, D. A. ; Rioux, J. D. / The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. In: Genes and Immunity. 2007 ; Vol. 8, No. 5. pp. 387-397.
@article{71e50e80b8104d359c144260759a9b74,
title = "The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases",
abstract = "The intestinal flora has long been thought to play a role either in initiating or in exacerbating the inflammatory bowel diseases (IBD). Host defenses, such as those mediated by the Toll-like receptors (TLR), are critical to the host/pathogen interaction and have been implicated in IBD pathophysiology. To explore the association of genetic variation in TLR pathways with susceptibility to IBD, we performed a replication study and pooled analyses of the putative IBD risk alleles in NFKB1 and TLR4, and we performed a haplotype-based screen for association to IBD in the TLR genes and a selection of their adaptor and signaling molecules. Our genotyping of 1539 cases of IBD and pooled analysis of 4805 cases of IBD validates the published association of a TLR4 allele with risk of IBD (odds ratio (OR): 1.30, 95{\%} confidence interval (CI): 1.15-1.48; P=0.00017) and Crohn's disease (OR: 1.33, 95{\%} CI: 1.16-1.54; P=0.000035) but not ulcerative colitis. We also describe novel suggestive evidence that TIRAP (OR: 1.16, 95{\%} CI: 1.04-1.30; P=0.007) has a modest effect on risk of IBD. Our analysis, therefore, offers additional evidence that the TLR4 pathway - in this case, TLR4 and its signaling molecule TIRAP - plays a role in susceptibility to IBD.",
author = "{De Jager}, {P. L.} and D. Franchimont and A. Waliszewska and A. Bitton and A. Cohen and D. Langelier and J. Belaiche and S. Vermeire and L. Farwell and A. Goris and C. Libioulle and N. Jani and T. Dassopoulos and Bromfield, {G. P.} and B. Dubois and Cho, {J. H.} and Brant, {S. R.} and Duerr, {R. H.} and H. Yang and Rotter, {J. I.} and Silverberg, {M. S.} and Steinhart, {A. H.} and Daly, {M. J.} and Podolsky, {D. K.} and E. Louis and Hafler, {D. A.} and Rioux, {J. D.}",
year = "2007",
month = "7",
doi = "10.1038/sj.gene.6364398",
language = "English (US)",
volume = "8",
pages = "387--397",
journal = "Genes and Immunity",
issn = "1466-4879",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases

AU - De Jager, P. L.

AU - Franchimont, D.

AU - Waliszewska, A.

AU - Bitton, A.

AU - Cohen, A.

AU - Langelier, D.

AU - Belaiche, J.

AU - Vermeire, S.

AU - Farwell, L.

AU - Goris, A.

AU - Libioulle, C.

AU - Jani, N.

AU - Dassopoulos, T.

AU - Bromfield, G. P.

AU - Dubois, B.

AU - Cho, J. H.

AU - Brant, S. R.

AU - Duerr, R. H.

AU - Yang, H.

AU - Rotter, J. I.

AU - Silverberg, M. S.

AU - Steinhart, A. H.

AU - Daly, M. J.

AU - Podolsky, D. K.

AU - Louis, E.

AU - Hafler, D. A.

AU - Rioux, J. D.

PY - 2007/7

Y1 - 2007/7

N2 - The intestinal flora has long been thought to play a role either in initiating or in exacerbating the inflammatory bowel diseases (IBD). Host defenses, such as those mediated by the Toll-like receptors (TLR), are critical to the host/pathogen interaction and have been implicated in IBD pathophysiology. To explore the association of genetic variation in TLR pathways with susceptibility to IBD, we performed a replication study and pooled analyses of the putative IBD risk alleles in NFKB1 and TLR4, and we performed a haplotype-based screen for association to IBD in the TLR genes and a selection of their adaptor and signaling molecules. Our genotyping of 1539 cases of IBD and pooled analysis of 4805 cases of IBD validates the published association of a TLR4 allele with risk of IBD (odds ratio (OR): 1.30, 95% confidence interval (CI): 1.15-1.48; P=0.00017) and Crohn's disease (OR: 1.33, 95% CI: 1.16-1.54; P=0.000035) but not ulcerative colitis. We also describe novel suggestive evidence that TIRAP (OR: 1.16, 95% CI: 1.04-1.30; P=0.007) has a modest effect on risk of IBD. Our analysis, therefore, offers additional evidence that the TLR4 pathway - in this case, TLR4 and its signaling molecule TIRAP - plays a role in susceptibility to IBD.

AB - The intestinal flora has long been thought to play a role either in initiating or in exacerbating the inflammatory bowel diseases (IBD). Host defenses, such as those mediated by the Toll-like receptors (TLR), are critical to the host/pathogen interaction and have been implicated in IBD pathophysiology. To explore the association of genetic variation in TLR pathways with susceptibility to IBD, we performed a replication study and pooled analyses of the putative IBD risk alleles in NFKB1 and TLR4, and we performed a haplotype-based screen for association to IBD in the TLR genes and a selection of their adaptor and signaling molecules. Our genotyping of 1539 cases of IBD and pooled analysis of 4805 cases of IBD validates the published association of a TLR4 allele with risk of IBD (odds ratio (OR): 1.30, 95% confidence interval (CI): 1.15-1.48; P=0.00017) and Crohn's disease (OR: 1.33, 95% CI: 1.16-1.54; P=0.000035) but not ulcerative colitis. We also describe novel suggestive evidence that TIRAP (OR: 1.16, 95% CI: 1.04-1.30; P=0.007) has a modest effect on risk of IBD. Our analysis, therefore, offers additional evidence that the TLR4 pathway - in this case, TLR4 and its signaling molecule TIRAP - plays a role in susceptibility to IBD.

UR - http://www.scopus.com/inward/record.url?scp=34547459989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547459989&partnerID=8YFLogxK

U2 - 10.1038/sj.gene.6364398

DO - 10.1038/sj.gene.6364398

M3 - Article

C2 - 17538633

AN - SCOPUS:34547459989

VL - 8

SP - 387

EP - 397

JO - Genes and Immunity

JF - Genes and Immunity

SN - 1466-4879

IS - 5

ER -